Mode of action of ticagrelor at the human platelet P2Y12-receptor

被引：0
|
作者：
Hoffmann, K. [1 ]
von Kuegelgen, I [1 ]
机构：
[1] Univ Bonn, Inst Pharmakol & Toxikol, D-53127 Bonn, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2013年 / 386卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
138
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [31] Reversal Strategy For Antagonizing The P2Y12-Inhibitor Ticagrelor By Platelet Concentrates
    Eva-Luise, Hobl
    Jilma-Stohlawetz, Petra
    Derhaschnig, Ulla
    Christian, Schoergenhofer
    Schwameis, Michael
    Jilma, Bernd
    BLOOD, 2013, 122 (21)
  • [32] Ticagrelor enhances platelet TP receptor surface expression in patients due to P2Y12/TP dimerization
    Keith, Michael
    Hutchinson, Lawrence
    Khalil, Jawad
    Mundell, Stuart
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (04) : 491 - 492
  • [33] Aspirin augments the anti-platelet effects of partial but not complete P2Y12 receptor blockade by ticagrelor
    Kirkby, N. S.
    Leadbeater, P. D. M.
    Chan, M., V
    Nylander, S.
    Mitchell, J. A.
    Warner, T. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 780 - 780
  • [34] IN VITRO PHARMACODYNAMIC EFFECTS OF CANGRELOR ON PLATELET P2Y12 RECEPTOR MEDIATED SIGNALING IN TICAGRELOR TREATED PATIENTS
    Rollini, Fabiana
    Franchi, Francesco
    Thano, Estela
    Faz, Gabriel
    Park, Yongwhi
    Hu, Jenny
    Kureti, Megha
    Aggarwal, Niti
    Durairaj, Ashwin
    Cho, Jung Rae
    Been, Latonya
    Alobaidi, Zeina
    Zenni, Martin
    Bass, Theodore
    Angiolillo, Dominick
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 213 - 213
  • [35] Efficacy and Safety of Ticagrelor: A Reversible P2Y12 Receptor Antagonist
    Anderson, Shawn D.
    Shah, Niren K.
    Yim, Juwon
    Epstein, Benjamin J.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 524 - 537
  • [36] P2Y12-receptor knockout leads to reduced myocardial ischemia/reperfusion injury in mice
    Maier, A.
    Duerschmied, D.
    Von Elverfeldt, D.
    Mauler, M.
    Moritz, M.
    Witsch, T.
    Neudorfer, I.
    Peter, K.
    Bode, C.
    Von Zur Muehlen, C.
    EUROPEAN HEART JOURNAL, 2015, 36 : 353 - 353
  • [37] Studies of the interaction of ticagrelor with the P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes
    Bjorquist, Anna
    Di Buduo, Christian A.
    Femia, Eti A.
    Storey, Robert F.
    Becker, Richard C.
    Balduini, Alessandra
    Nylander, Sven
    Cattaneo, Marco
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (06) : 1079 - 1088
  • [38] Active metabolites of clopidogrel acting as antagonists at the P2Y12-receptor in processes of differentiated PC12 cells
    Kulick, MB
    von Kügelgen, I
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R32 - R32
  • [39] Impact of ticagrelor on P2Y1 and P2Y12 localization and on Cholesterol levels in platelet plasma membrane
    Rabani, V.
    Montange, D.
    Meneveau, N.
    Davani, S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1135 - 1135
  • [40] Impact of ticagrelor on P2Y1 and P2Y12 localization and on cholesterol levels in platelet plasma membrane
    Rabani, Vahideh
    Montange, Damien
    Meneveau, Nicolas
    Davani, Siamak
    PLATELETS, 2018, 29 (07) : 709 - 715
12345